Pfizer COVID pill gets final approval from European Commission
Reuters2022-01-28
Jan 28 (Reuters) - The European Commission on Friday approved Pfizer's antiviral pill for COVID-19 a day after the region's health regulator endorsed the tablet, a move that will ensure wide availability of the promising treatment to EU member states.
The final go-ahead by the executive body of the European Union $(EU)$ was tweeted
by EU Health Commissioner Stella Kyriakides as the region is beefing up its defences against the coronavirus amid the rapid spread of the new Omicron variant.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shinjini Ganguli)
((Pushkala.A@thomsonreuters.com; Twitter: @pullthekart; Mobile: +91 852 751 3793 ;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
